ArticleOphthalmology science

Phase I DAVIO Trial: EYP-1901 Bioerodible, Sustained-Delivery Vorolanib Insert in Patients With Wet Age-Related Macular Degeneration.

Sunil Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.